Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Wanneer starten met levodopa? Resultaten van de LEAP-studie
feb 2019 | Bewegingsstoornissen